According to the company, the Obagi Rosaclear System is the first and only complete prescription-based system developed specifically for treating the signs and symptoms of rosacea.
The all-in-one system is designed to reduce redness and flushing, along with treating papules and pustules, to help rosacea patients achieve a clearer, calmer and more balanced-looking complexion. The Rosaclear System will be available through physicians beginning in January and will be promoted by Obagi’s dermatology and medical aesthetics sales forces.
In a recent clinical study, 90% of subjects showed at least a one grade reduction in the severity of rosacea after just two weeks. Investigators also reported an overall reduction in redness and continued improvement over the four-week study, the company said.
According to the company, the Rosaclear System incorporates a specially formulated treatment regimen that effectively reduces and minimizes the visible redness and blotchiness associated with rosacea and is also non-comedogenic, so it won’t clog pores.
Steven Carlson, CEO of Obagi Medical Products, said: The launch of our Rosaclear System provides physicians with a highly effective option for treating rosacea and exemplifies Obagi’s commitment to providing the most complete aesthetic and therapeutic skin care systems and products.